Last Updated: August 9, 2026

OXYCODONE AND ACETAMINOPHEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Oxycodone And Acetaminophen patents expire, and when can generic versions of Oxycodone And Acetaminophen launch?

Oxycodone And Acetaminophen is a drug marketed by Actavis Elizabeth, Barr, Duramed Pharms Barr, Halsey, Mallinckrodt, Mutual Pharm, Vintage Pharms, Vintage Pharms Llc, Watson Labs, Abhai Llc, Mikart, Sankalp Lifecare, Specgx Llc, Alvogen, Amneal Pharms, Amneal Pharms Ny, Ascent Pharms Inc, Aurolife Pharma Llc, Chartwell, Dr Reddys Labs Sa, Elite Labs Inc, Epic Pharma Llc, Granules, Lannett Co Inc, Nesher Pharms, Novel Labs Inc, Ph Health, Rhodes Pharms, Sanaluz, Sun Pharm Inds Inc, and Wes Pharma Inc. and is included in fifty-one NDAs.

The generic ingredient in OXYCODONE AND ACETAMINOPHEN is acetaminophen; oxycodone hydrochloride. There are sixty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the acetaminophen; oxycodone hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for OXYCODONE AND ACETAMINOPHEN?
  • What are the global sales for OXYCODONE AND ACETAMINOPHEN?
  • What is Average Wholesale Price for OXYCODONE AND ACETAMINOPHEN?
Summary for OXYCODONE AND ACETAMINOPHEN
Recent Clinical Trials for OXYCODONE AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of South AlabamaPHASE4
Texas Scottish Rite Hospital for ChildrenPHASE2
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityNA

See all OXYCODONE AND ACETAMINOPHEN clinical trials

Pharmacology for OXYCODONE AND ACETAMINOPHEN
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information for OXYCODONE AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040698-001 Apr 27, 2006 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Watson Labs OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040371-002 Dec 29, 2000 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Barr OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 087406-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Amneal Pharms Ny OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 040789-002 Nov 27, 2007 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ph Health OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 090734-002 Jul 11, 2013 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Dr Reddys Labs Sa OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 090177-005 Oct 20, 2008 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Granules OXYCODONE AND ACETAMINOPHEN acetaminophen; oxycodone hydrochloride TABLET;ORAL 211708-003 Oct 31, 2019 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.